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Abstract
Background: The hospital environment has been suggested as playing an important role in the transmission of
hospital-associated (HA) pathogens. However, studies investigating the contamination of the hospital environment
with methicillin-resistant Staphylococcus aureus (MRSA) or Clostridium difficile have generally focused on point
prevalence studies of only a single pathogen. Research evaluating the roles of these two pathogens, concurrently,
in the general hospital environment has not been conducted. The objectives of this study were to determine the
prevalence and identify risk factors associated with MRSA and C. difficile contamination in the general environment
of three community hospitals, prospectively.
Methods: Sampling of environmental surfaces distributed over the medicine and surgical wards at each hospital
was conducted once a week for four consecutive weeks. Sterile electrostatic cloths were used for environmental
sampling and information regarding the surface sampled was recorded. For MRSA, air sampling was also
conducted. Enrichment culture was performed and spa typing was performed for all MRSA isolates. For C. difficile,
isolates were characterized by ribotyping and investigated for the presence of toxin genes by PCR. Using logistic
regression, the following risk factors were examined for MRSA or C. difficile contamination: type of surface sampled,
surface material, surface location, and the presence/absence of the other HA pathogen under investigation.
Results: Overall, 11.8% (n=612) and 2.4% (n=552) of surfaces were positive for MRSA and C. difficile, respectively.
Based on molecular typing, five different MRSA strains and eight different C. difficile ribotypes, including ribotypes
027 (15.4%) and 078 (7.7%), were identified in the hospital environment. Results from the logistic regression model
indicate that compared to computer keyboards, the following surfaces had increased odds of being contaminated
with MRSA: chair backs, hand rails, isolation carts, and sofas.
Conclusions: MRSA and C. difficile were identified from a variety of surfaces in the general hospital environment.
Several surfaces had an increased risk of being contaminated with MRSA but further studies regarding contact rates,
type of surface material, and the populations using these surfaces are warranted.
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Background
Methicillin-resistant Staphylococcus aureus (MRSA) and
Clostridium difficile are two leading hospital-associated
(HA) pathogens with both being important causes of
patient morbidity and mortality [1,2], outbreaks [3,4],
and substantial healthcare costs [5,6]. While data are
incomplete and sometimes conflicting, the environment
has been suggested as being an important source for
the transmission of HA pathogens [7–9], however, the
precise role of environmental contamination in HA
infections remains unclear [10]. Several studies have
been conducted concerning the epidemiology of MRSA
[8,11,12] and C. difficile [13–16] transmission within
healthcare facilities. Although studies have been pub-
lished surveying the environment in patient rooms
[12,15,17–22], information pertaining to MRSA and C.
difficile contamination in the general hospital environ-
ment is limited. Furthermore, there has been little
research involving community hospitals, since epidemio-
logical and microbiological studies have focused almost
exclusively on tertiary healthcare facilities [11,16–18].
While this approach provides important information, it
is unclear whether results from tertiary care facilities are
applicable to smaller community hospitals, and therefore
whether recommendations based on tertiary care hos-
pital data are broadly applicable.
Studies investigating contamination of the hospital
environment with MRSA or C. difficile have generally
focused on one pathogen [11–15]. Research evaluating
the concurrent roles of these two HA pathogens in the
general hospital environment has not been conducted
and potential associations or commonalities between
environmental contamination with MRSA and C. diffi-
cile have not been investigated. As some hospitals lack
the laboratory equipment necessary to culture C. diffi-
cile, the investigators hypothesized that if there was a
correlation or association between MRSA and C. difficile
at the sample level, consequently, hospitals that con-
ducted environmental audits or surveillance for MRSA
could reasonably presume that the surface was also con-
taminated with C. difficile. Furthermore, longitudinal
information pertaining to risk factors for environmental
contamination, such as specific environmental surfaces
sampled or surface material (e.g., fabric versus plastic
as it relates to decontamination potential) outside of an
outbreak scenario has not been explored. The data pro-
vided by this type of research can be used by infection
control personnel to guide surveillance, and assess and
implement environmental control measures for reducing
contamination of the general hospital environment with
MRSA and C. difficile.
The objectives of this study were to determine the
prevalence of MRSA and C. difficile in the general
hospital environment, determine what environmental
surfaces and type of surfaces were most likely contami-
nated with MRSA and C. difficile, identify if access by
staff or the public was associated with increased MRSA
and C. difficile contamination, and compare MRSA and
C. difficile strains between patients and the environment.
Methods
Setting
Three community hospitals, referred to as A, B, and C,
located in southern Ontario, Canada, participated in this
study. Information pertaining to each healthcare facility
is presented in Table 1. Environmental sampling was
conducted in February and March, 2010 in hospitals A
and B and June 2010 for hospital C. During the study
period, none of the hospitals identified MRSA or C. diffi-
cile outbreaks. This study was approved by the research
ethics boards of the University of Guelph and the par-
ticipating hospitals.
Sampling
Structured sampling of a pre-determined set of environ-
mental surfaces distributed over the general medicine
and surgical wards at each participating hospital was
conducted one day a week for four consecutive weeks.
The selection of surfaces to be investigated for contam-
ination was based on data presented in previous studies
[11,13,20] and through discussion with hospital staff
regarding cleaning and disinfection practices. Environ-
mental surfaces were sampled four times as this would
provide good quality data regarding contamination in
the general ward environment. Surfaces sampled were
broadly replicable between wards and hospitals, in
addition to sites that were relevant and specific to each
ward. Surfaces were sampled prior to that day’s cleaning
by housekeeping staff. All hospitals used a one step
cleaner and disinfectant protocol and wards were
cleaned once per day. No changes in the cleaning proto-
col were instituted during the study period.
Dry sterile electrostatic cloths (Swiffer™, Proctor and
Gamble, USA) were used for environmental sampling.
Using a gloved hand, the investigator wiped the electro-
static cloth over half the environmental surface to be
sampled, up to a maximum of 20 cm x 20 cm. The cloth
was then placed in a sterile collection bag (Whirl-PakW,
Nasco, California, USA). A second electrostatic cloth
was used to sample the other half of the environmental
surface. Gloves were changed between each sample.
During each hospital visit, two electrostatic cloths were
not used for sampling but were handled and processed
in parallel, to act as negative controls for quality assur-
ance. Information collected with each surface sampled
included: date, hospital, hospital ward, type of surface (e.g.,
sofa), surface material (e.g., fabric), and if the surface was
accessible by the public or only by hospital staff. For
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MRSA, impact air sampling was also performed using an
air IDEAL W3P air sampler (Biomérieux, Saint Laurent,
Quebec, Canada) in elevator areas, nurses’ stations, and
waiting rooms. A total of 500 L of air was collected onto
selective MRSA culture agar (BBL CHROMagar MRSA,
Becton, Dickinson and Company, Sparks, Maryland,
USA) over a five minute period. Air sampling was con-
ducted at a height of 1 metre and a minimum of 1 metre
from the nearest surface.
From all participating facilities, MRSA isolates from
patients hospitalized in the medical and surgical wards
during the study period were obtained from the micro-
biology laboratory following MRSA confirmation. Iso-
lates were collected from culture plates using a culture
swab with Stuart’s media. Stool samples from patients
diagnosed with a C. difficile infection by a fecal toxin
test (Tox A/B Quik Chek, TechLab, Blacksburg, Vir-
ginia, USA) were obtained from Hospital C only. All
isolates were collected at the discretion of medical
personnel. For MRSA and C. difficile, only one isolate
per patient was collected.
Processing
For MRSA, cloths were immersed in 30 ml of enrich-
ment broth containing tryptone (10g/L), sodium chloride
(75 g/L), mannitol (10g/L), and yeast extract (2.5g/L)
and incubated at 35°C, aerobically, for 24 hours. Fol-
lowing incubation, approximately 5 μL of broth was
inoculated onto MRSA Chromogenic agar (BBL CHRO-
Magar MRSA, Becton, Dickinson and Company,
Sparks, Maryland, USA) and incubated, aerobically, at
35°C for 24-48 hours. Colonies with an appearance
consistent with MRSA were sub-cultured onto blood
agar (Oxoid, Nepean, Ontario, Canada) and identified
as S. aureus by Gram stain, catalase test, tube coagulase
test, and S. aureus latex agglutination assay (Pastorex
Staph-plus, Bio-Rad Laboratories Ltd, Mississauga,
Ontario, Canada). The presence of methicillin-resistance
was confirmed by testing for penicillin-binding protein
2a (MRSA latex agglutination test, Oxoid Ltd., Hants,
UK). For air samples, agar plates were incubated and pro-
cessed as described above. For patient isolates, culture
swabs were streaked onto blood agar (Oxoid, Nepean,
Ontario, Canada) and processed as described above. Mo-
lecular typing of MRSA was conducted using sequence
analysis of the X region of the staphylococcal protein A
gene (spa typing) [23]. Sequences were then analyzed
using two different methods; eGenomics software [24]
and the Ridom system [25]. Based on eGenomics, spa
types are reported using a numerical system (e.g., spa
type 2) whereas Ridom spa types are reported using a nu-
merical system preceded by a ‘t’ (e.g., t002). The spa
types obtained were compared to epidemic MRSA clones
that are frequently found in North America [26]. All
MRSA isolates were investigated for the lukF-PV gene
encoding the Panton-Valentine leukocidin toxin by real-
time PCR [27].
For C. difficile, cloths were immersed in 30 ml of
brain-heart infusion broth supplemented with 0.1%
sodium taurocholate and incubated anaerobically at
37°C for 5 days. A 2 ml aliquot of broth was alcohol
shocked by addition of an equal volume of anhydrous
alcohol and incubated at room temperature for one hour
followed by centrifugation at 4,000 rpm for 10 min. The
resulting pellet was then inoculated onto C. difficile
moxalactam-norfloxacin agar (Oxoid, Nepean, Ontario,
Canada) and incubated anaerobically for 24-96 hours
at 37°C. Presumptive colonies were sub-cultured onto
blood agar (Oxoid, Nepean, Ontario, Canada) and identi-
fied as C. difficile based on characteristic colony morph-
ology, odour, and production of L-proline-aminopeptidase
(Prodisk, Remel, Lenexa, Kansas, USA). For patient iso-
lates, approximately 1 g of feces was inoculated into 9 ml
of brain-heart infusion broth and processed as described
above. All isolates identified as C. difficile were investi-
gated for the presence of genes for toxin A (tcdA) [28],
toxin B (tcdB) [29], and binary toxin (cdtA) [30] using
PCR. Ribotyping was also performed [31]. When a
Table 1 Description of participating hospitals
Features Hospital
A B C
Number of beds 345 191 226
Number of in- and out- patient visits, 2010 >200,000 >150,000 >100,000
Range of MRSA infection1 rates per 1,000 patient-days, 2009 and 2010 2009: 0.00 – 0.08 2009: 0.00 – 1.07 2009: 0.00 – 0.17
2010: 0.00 – 0.11 2010: 0.00 – 0.08 2010: 0.00 – 0.08
MRSA infection1 rates per 1,000 patient-days, 2010 for month of sampling 0.07 0.08 0.00
Range of Clostridium difficile infection rates per 1,000 patient-days, 2009 and 2010 2009: 0.13 – 0.67 2009: 0.24 – 1.31 2009: 0.00 – 0.56
2010: 0.00 – 0.36 2010: 0.00 – 0.98 2010: 0.00 – 0.79
C. difficile infection rates per 1,000 patient-days, 2010 for month of sampling 0.26 0.76 0.79
1 Rates for bacteremia.
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ribotype pattern was known to be an international ribo-
type based on comparison to reference strains, the
appropriate numerical designation (e.g., 027) was assigned.
Otherwise, an internal laboratory designation was assigned.




The prevalence of MRSA and C. difficile contamination
by visit, ward, surface material, surface location, and type
of surface was determined for each hospital. If the overall
prevalence of MRSA or C. difficile in the general ward
environment was at least 10%, a regression model was
constructed to identify risk factors for contamination.
Statistical models
Initially, a multilevel logistic regression model was con-
structed due to the hierarchical structure of the data.
The four-level hierarchical structure for this analysis
consisted of repeated samples nested in surfaces that
were nested in wards that were nested in hospitals. For
model building, the dependent variables were the pres-
ence or absence of MRSA or C. difficile on a surface.
Independent variables investigated included surface
material, surface location, type of surface sampled, and
the presence/absence of the other HA pathogen under
investigation. To control for clustering, the multilevel
logistic regression model included a fixed effect for hos-
pital and random intercepts for ward and surface.
The Spearman’s rank correlation test was used to iden-
tify correlations between independent variables and the
correlation between MRSA and C. difficile contamin-
ation at the sample level. Independent variables with a
correlation >0.8 were investigated and only the variable
that was more biologically plausible was included in the
model to avoid issues associated with collinearity [33].
Additionally, for common surfaces, a paired exact logis-
tic regression was conducted to determine if there were
any significant differences in the probability of a surface
being contaminated with MRSA or C. difficile.
Univariable logistic regression models were con-
structed to screen the independent variables with each
dependent variable using a significance level of α ≤0.25.
Multivariable models were constructed by a manual
backwards step-wise procedure starting with all signifi-
cant variables based on the liberal P-value. Confounding
was evaluated by examining the effect of the removed
variables on the coefficients of the remaining variables.
A variable was deemed to be a confounder if it was not
an intervening variable and the log odds of a statistically
significant independent variable changed by at least 20%
[34]. Interaction terms were examined for all independ-
ent variables in the final main effects model. Using the
final multivariable model, the investigators examined
contrasts for independent variables with >2 categories.
These contrasts allowed the researchers to investigate
significant differences between any two categories.
Random intercepts were removed from the model if,
based on a likelihood ratio (LR) test, they were not sta-
tistically significant and they did not confound the
observed associations. Similarly, Akaike’s Information
Criteria (AIC) were examined among models with and
without the random intercepts to assess which model
provided the best fit. If random effects were included in
the final model, standardized Pearson residuals were
assessed to identify outliers. In addition, normality and
homogeneity of variance for the best linear unbiased
predictors were examined to assess model fit. If random
effects were not included in the final model, a Pearson
χ2 test was used to assess model fit and standardized
Pearson residuals were evaluated to identify outliers.
All descriptive statistics, model building, and analyses
were performed using Stata 11.0 (StataCorp LP, College
Station, Texas, USA). All tests were two-sided and statis-
tical significance was based on an α ≤ 0.05.
Results
Descriptive statistics
Due to the low number of surfaces positive for C. diffi-
cile, a statistical model could not be constructed for
C. difficile. Consequently, only descriptive statistics for
C. difficile are reported.
From the three participating hospitals, 208 different
surfaces, for a total of 612 samples, were tested for
MRSA, while 191 different surfaces, for a total of
552 samples, were tested for C. difficile. Overall, 11.8%
(72/612; 95% CI 9.30-14.6%) and 2.4% (13/552; 95% CI
Table 2 Prevalence of MRSA and C. difficile contamination of surfaces that tested positive at least once
Pathogen Hospital Overall total prevalence
(95% CI; n)A B C
Prevalence (95% CI; n) Prevalence (95% CI; n) Prevalence (95% CI; n)
MRSA 20.5% (12.6-30.4; 18/88) 30.8% (19.9-43.4; 20/65) 47.3% (33.7-61.2; 26/55) 30.8% (24.6-37.5; 64/208)
Clostridium difficile 7.3% (2.7-15.2; 6/82) 3.4% (0.4-11.7; 2/59) 10% (3.3-21.4; 5/50) 6.8% (3.7-11.4; 13/191)
CI: confidence interval.
n: number of samples.
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Table 3 Descriptive statistics of variables for MRSA and C. difficile contamination in the general hospital environment
Hospital
A B C
Variables MRSA (n) C. difficile (n) MRSA (n) C. difficile (n) MRSA (n) C. difficile (n)
Visit:
1 6.5% (3/46) 2.5% (1/40) 6.7% (3/45) 0% (0/39) 0% (0/42) 0% (0/37)
2 3.7% (2/54) 0% (0/50) 9.1% (5/55) 2.0% (1/49) 53.1% (26/49) 0% (0/44)
3 8.5% (4/47) 0% (0/44) 22.8% (13/57) 2.0% (1/51) 0% (0/51) 2.2% (1/46)
4 18.3% (11/60) 8.8% (5/57) 7.0% (4/57) 0% (0/51) 2.0% (1/49) 9.1% (4/44)
Ward:
Medical 8.2% (11/135) 1.6% (2/126) 9.2% (6/65) 0% (0/57) 14.8% (17/115) 3.9% (4/103)
Surgical 12.5% (9/72) 6.2% (4/65) 12.8% (19/149) 1.5% (2/133) 13.2% (10/76) 1.5% (1/68)
Surface material:
Air 6.3% (1/16) na 12.5% (3/24) na 0% (0/20) na
Fabric 8.6% (3/35) 2.9% (1/35) 21.1% (8/38) 2.6% (1/38) 22.4% (15/67) 3.0% (2/67)
Laminate 5.3% (1/19) 0% (0/19) 16.7% (2/12) 0% (0/12) 25.0% (3/12) 16.7% (2/12)
Leather na na na na 0% (0/2) 0% (0/2)
Metal 9.1% (2/22) 0% (0/22) 14.8% (4/27) 0% (0/27) 10.7% (3/28) 0% (0/28)
Mixed 11.1% (1/9) 0% (0/9) 30.0% (3/10) 10.0% (1/10) na na
Plastic 10.7% (11/103) 4.9% (5/103) 5.2% (5/97) 0% (0/97) 11.1% (6/54) 1.9% (1/54)
Wood 33.3% (1/3) 0% (0/3) 0% (0/6) 0% (0/6) 0% (0/8) 0% (0/8)
Surface location:
Public access 11.0% (17/155) 2.1% (3/144) 11.9% (19/160) 1.4% (2/148) 12.9% (17/131) 3.3% (4/120)
Staff access 5.8% (3/52) 6.4% (3/47) 11.1% (6/54) 0% (0/42) 16.7% (10/60) 1.9% (1/52)
Type of surface:
Antibacterial wipes container 0% (0/6) 0% (0/6) 25.0% (1/4) 0% (0/4) na na
Blood pressure machine 6.7% (1/15) 0% (0/15) 0% (0/12) 0% (0/12) 12.5% (1/8) 0% (0/8)
Brochure holder 0% (0/3) 0% (0/3) na na na na
Bulletin board 0% (0/2) 0% (0/2) 0% (0/2) 0% (0/2) 28.6% (2/7) 0% (0/7)
Chair back 12.5% (1/8) 0% (0/8) 22.2% (4/18) 0% (0/18) 19.4% (6/31) 0% (0/31)
Chart holder na na 0% (0/9) 0% (0/9) na na
Clip board na na na na 12.5% (1/8) 0% (0/8)
Computer keyboard 8.0% (2/25) 12.0% (3/25) 6.9% (2/29) 0% (0/29) 0% (0/8) 0% (0/8)
Counter top 0% (0/9) 0% (0/9) 16.7% (2/12) 0% (0/12) 25.0% (2/8)) 12.5% (1/8)
Door knob 0% (0/3) 0% (0/3) na na 0% (0/6) 0% (0/6)
Drug cart 19.1% (4/21) 4.8% (1/21) na na 0% (0/8) 0 % (0/8)
Elevator panel 0% (0/12) 0% (0/12) 0% (0/12) 0% (0/12) 25.0% (2/8) 0% (0/8)
Glove box holder 33.3% (2/6) 16.7% (1/6) na na na na
Hand rail 18.8% (3/16) 0% (0/16) 33.3% (4/12) 0% (0/12) 0% (0/8) 0% (0/8)
Heating oven handle na na na na 14.3% (1/7) 0% (0/7)
Isolation cart 10.0% (1/10) 0% (0/10) 25.0% (3/12) 8.3% (1/12) 14.3% (1/7) 14.3% (1/7)
Isolation gown 25.0% (1/4) 0% (0/4) 10.0% (1/10) 0% (0/10) 0% (0/7) 14.3% (1/7)
Lamp shade na na na na 33.3% (1/3) 0% (0/3)
Lifter handle na na na na 0% (0/3) 0% (0/3)
Linen 0% (0/17) 0% (0/17) 0% (0/12) 8.3% (1/12) 23.1% (3/13) 0% (0/13)
Patient chart 8.3% (1/12) 0% (0/12) 0% (0/21) 0% (0/21) 12.5% (1/8) 12.5% (1/8)
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1.3-3.9%) of surfaces sampled were positive for MRSA
and C. difficile, respectively. For common surfaces, there
was no significant difference in the prevalence between
MRSA and C. difficile (OR=1.13; 95% CI 0.15–6.92;
P=0.999). The Spearman’s correlation coefficient indi-
cated that MRSA and C. difficile contamination was not
correlated at the sample level (ρ=0.05; P=0.233). The
proportion of surfaces that tested positive at least once
for MRSA or C. difficile is presented in Table 2, with
Hospital C identified as having the highest prevalence
of both MRSA and C. difficile in the general environ-
ment. Data pertaining to the prevalence of MRSA and
C. difficile based on visit, ward, surface material, surface
location, and surface sampled are presented in Table 3.
Over the study period, the prevalence of MRSA and
C. difficile fluctuated in all three hospitals. None of
the negative control cloths tested positive for MRSA or
C. difficile.
Among the 72 MRSA isolates collected from the
hospital environment, seven different spa types were
identified (Table 4). A total of 60 air samples were taken
during the study with 6.7% (n=4) positive for MRSA. All
MRSA air isolates were spa type 2/t002. Overall, 46
MRSA isolates from patients were obtained during the
study. Eight different spa types were identified (Table 4).
For C. difficile, eight different ribotypes were identified
among the 13 isolates from the environment including
internationally recognized ribotypes 027 (15.4%, n=2)
and 078 (7.7%, n=1). Five C. difficile isolates, each represent-
ing a different ribotype, were collected from patients from
Hospital C only. Data pertaining to the characterization
of C. difficile isolates are presented in Table 5.
Surfaces positive on multiple visits
In Hospital A, a drug cart was contaminated with three
different spa types, 140/t954 (visit 1), 24/t242 (visit 3),
and 2/t002 (visit 4), all consistent with the Canadian epi-
demic MRSA (CMRSA) 2 clone. In Hospital B, a hand-
rail, an isolation cart, and an air sample taken in the
elevator area were contaminated with MRSA on two
visits each. For the isolation cart and elevator air sample,
all MRSA were identified as spa type 2/t002. However,
for the handrail, on visit two, spa type 2/t002 was identi-
fied and on visit 4 spa type 539/t034 was identified. In
Hospital B, a sofa was identified as being contaminated
with spa type 2/t002 on three different visits. In Hospital
C, the back of a chair located in a nursing station was
identified as being contaminated with MRSA on more
than one visit; spa type 7/t064 on visit two and spa type
1/t008 on visit 4. No surfaces were identified as being
contaminated with C. difficile on more than one visit.
Three surfaces were identified as being contaminated
with both MRSA and C. difficile on the same visit. These
surfaces included a glove box holder and a visiting room
sofa in Hospital A and an isolation cart in Hospital
B. Four surfaces were identified with being contaminated
with MRSA and C. difficile, on different visits. These
surfaces included a drug cart in Hospital A, and a nurs-
ing station counter top, an isolation cart, and a patient
chart in Hospital C.
Statistical model
For the initial univariable analysis, the variables surface
material, type of surface, hospital, and the presence of
C. difficile were significant at the 25% level for the pres-
ence of MRSA on a surface (Table 6). There was no sta-
tistically significant association in the univariable models
between type of ward and MRSA contamination, or sur-
face location and MRSA contamination.
For the final multivariable model, three variables were
included: hospital, surface location, and type of surface
(Table 7). In constructing the multilevel models for
MRSA contamination, the size of the variance compo-
nents for ward and surface were extremely small (e.g.,
<10-6). Furthermore, the LR test was not statistically
significant (P>0.99) comparing models with one or both
random intercepts compared to a regular logistic regres-
sion model. Similarly, the AIC was smaller when the
random effects were not included. Therefore, a regular
logistic regression model was used. The variable hospital
Table 3 Descriptive statistics of variables for MRSA and C. difficile contamination in the general hospital environment
(Continued)
Sofa 28.6% (2/7) 14.3% (1/7) 57.1% (4/7) 0% (0/7) 27.3% (3/11) 9.1% (1/11)
Sofa pillow na na na na 33.3% (1/3) 0% (0/3)
Supply cart na na 8.3% (1/12) 0% (0/12) 25.0% (1/4) 0% (0/4)
Telephone 6.7% (1/15) 0% (0/15) 0% (0/6) 0% (0/6) na na
Urine collection container na na na na 20.0% (1/5) 0% (0/5)
Elevator area – air 12.5% (1/8) na 16.7% (2/12) na 0% (0/8) na
Nursing station - air 0% (0/5) na 8.3% (1/12) na 0% (0/8) na
Visiting room - air 0% (0/3) na na na 0% (0/4) na
na = not applicable as these surfaces/areas were not sampled or were not present in the general environment.
Faires et al. BMC Infectious Diseases 2012, 12:290 Page 6 of 14
http://www.biomedcentral.com/1471-2334/12/290
was forced into the final model as a fixed effect to con-
trol for clustering at the hospital level and the potential
confounding effects of management differences between
hospitals. Surface location was included in the final
model as it was a confounder for the variable type of
surface. The only statistically significant independent
variable in the final model was type of surface. Specifically,
results from the multivariable logistic regression model
indicated that the odds of contamination for chair backs,
hand rails, isolation carts, and sofas were significantly
higher than computer keyboards (Table 7). Statistically sig-
nificant contrasts between the different types of surface
categories are presented in Table 8. Similarly, the mean
predicted probabilities for surfaces contaminated with
MRSA, while fixing hospital and surface location at a
referent category, are presented in Figure 1. As demon-
strated in both model-based contrasts and the mean
predicted probabilities, sofas, hand rails, chair backs, and
isolation carts had a higher probability of being contami-
nated with MRSA compared to other surfaces commonly
found in the ward environment. Interactions between vari-
ables could not be assessed due to the large number of
categories for type of surface and the resulting small num-
ber of observations per interaction term.
Standardized Pearson residuals were assessed and only
two outliers were identified (i.e., residual values of 2.55
and 2.71). For both outliers, data were assessed, found to
be recorded correctly, and the observations were kept in
the final model. The Pearson χ2 test was not significant
(P=0.25) indicating that the model fits the data.
Discussion
This is the first study to explore the epidemiology of
both MRSA and C. difficile in the general ward












Environment: 1 2 3 4
A (20) 2 50.0% (10) t002 No 2 100 2 2 2 4
539 30.0% (6) t034 No No assignment No assignment 0 0 0 6
24 10.0% (2) t242 No 2 100 0 0 1 1
140 5.0% (1) t954 No 2 100 1 0 0 0
957 5.0% (1) t4867 No No assignment No assignment 0 0 1 0
B (25) 2 88.0% (22) t002 No 2 100 3 5 10 4
539 12.0% (3) t034 No No assignment No assignment 0 0 3 0
C (27) 1 3.7% (1) t008 Yes 10 300 0 0 0 1
7 96.3% (26) t064 No 5 500 0 26 0 0
Patients:
A (16)c 2 75.0% (12) t002 No 2 100 0 6 3 3
23 6.3% (1) t548 No 2 100 0 1 0 0
24 6.3% (1) t242 No 2 100 0 0 1 0
140 6.3% (1) t954 No 2 100 0 1 0 0
696 6.3% (1) t2069 No No assignment No assignment 0 1 0 0
B (25)d 2 80.0% (20) t002 No 2 100 6 4 7 3
1 4.0% (1) t008 No 5 500 0 0 1 0
12 4.0% (1) t062 No 2 100 1 0 0 0
23 4.0% (1) t548 No 2 100 0 0 0 1
24 4.0% (1) t242 No 2 100 0 0 0 1
230 4.0% (1) t010 No 2 100 1 0 0 0
C (5)e 2 80.0% (4) t002 No 2 100 0 0 2 2
1 20.0% (1) t008 Yes 10 300 0 0 1 0
PVL: Panton-Valentine leukocidin.
CMRSA: Canadian epidemic methicillin-resistant Staphylococcus aureus.
n = number of samples.
a spa types classified according to eGenomics (http://tools.egenomics.com)b spa types classified according to the Ridom system (http://www.spaserver.ridom.de).
c MRSA was isolated from the perianal region (62.5%, n=10) and the anterior nares (37.5%, n=6).
d MRSA was isolated from the perianal region (68%, n=17), the anterior nares (12%, n=3), and from wounds (20%, n=5).
e MRSA was isolated from the anterior nares (100%, n=5).
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environment of community hospitals. By investigating
MRSA and C. difficile contamination prospectively and
under endemic conditions, the information collected can
be used by various hospital personnel for surveillance
and infection and environmental control measures to re-
duce the transmission and dissemination of these HA
pathogens within the healthcare setting.
Overall, 11.8% and 2.4% of surfaces in the general
environment of the medical and surgical wards were
contaminated with MRSA and C. difficile, respectively.
In the literature, the prevalence of MRSA in the hospital
environment has ranged from 0.6% to 54% [11,17,35–37]
and for C. difficile the prevalence has ranged from 2.8%
to 50% [14,16,21,38,39]. These wide variations in the
reported prevalence of MRSA and C. difficile conta-
mination may be attributed to different study designs,
including sampling times (endemic versus outbreak set-
tings), the presence of colonized and/or infected patients
during sampling, sampling in different hospital wards,
sampling pre- and post-disinfection, sampling surfaces
once versus multiple times, and the use of different sam-
pling techniques and culture methodologies. Further-
more, the majority of studies investigating MRSA and
C. difficile have been conducted almost exclusively in
patient rooms [12,15,17–22] as opposed to this study
which examined the general hospital environment.
Therefore, care must be taken when comparing preva-
lence data between studies.
With respect to the general ward environment, limited
information on MRSA and C. difficile contamination
exists in the literature. Dancer and colleagues [8]
screened the computer keyboard, desk, and patient notes
located in nursing work stations in two surgical wards
during their year-long investigation. In nurses’ work sta-
tions, 2.2% (95% CI 0.9-4.6%) of samples were positive
for MRSA. Dumford and colleagues [13] conducted a
point-prevalence culture survey for toxigenic C. difficile
strains in physician and nurse work areas, specifically
targeting telephones, tabletops, computer keyboards,
and door knobs on eight different wards. Results from
their investigation revealed that 31% (95% CI 15.3-50.8)
and 10% (95% CI 0.3-44.5%) of surfaces in physician and
nursing work areas, respectively, were contaminated
with C. difficile. In the present study, the overall preva-
lence of MRSA and C. difficile on surfaces located in
areas accessible only by hospital personnel ranged from
5.8-16.7% and 0-6.4%, respectively. Surfaces sampled
included patient charts, computer keyboards, chair
backs, and telephones. These surfaces are repeatedly
touched by staff throughout the day or immediately after
patient contact or leaving an isolation room. Therefore,
contamination may be attributed to a number of factors
including lack of hand hygiene, failure to use personnel
protective equipment, the inability to properly disinfect
a surface, inconsistent cleaning schedules, or the quality
of cleaning and disinfection protocols.
The dispersal of MRSA in air has been documented in
rooms with MRSA positive patients [17,40]. However,
information with respect to MRSA outside of patients’
rooms is limited and the role of airborne or aerosolized
Table 5 Typing data for C. difficile isolated from the general environment and patients
Hospital (n) Ribotype % per hospital (n) Toxinotype Toxin genes Visit number (n)
Environment: 1 2 3 4
A (6) 027 16.7% (1) III tcdA, tcdB, cdtA 0 0 0 1
078 16.7% (1) V tcdA, tcdB, cdtA 1 0 0 0
MOH-AD 16.7% (1) III tcdA, tcdB, cdtA 0 0 0 1
MOH-O 16.7% (1) 0 tcdA, tcdB 0 0 0 1
GRH-A 16.7% (1) Not tested None 0 0 0 1
OVC-J 16.7% (1) Not tested None 0 0 0 1
B (2) 027 50.0% (1) III tcdA, tcdB, cdtA 0 0 1 0
MOH-C 50.0% (1) IX tcdA, tcdB, cdtA 0 1 0 0
C (5) MOH-T 80.0% (4) 0 tcdA, tcdB 0 0 1 3
OVC-J 20.0% (1) Not tested None 0 0 0 1
Patients:
C (5) MOH-AG 20.0% (1) 0 tcdA, tcdB 0 0 1 0
MOH-T 20.0% (1) 0 tcdA, tcdB 0 0 1 0
MOH-V 20.0% (1) 0 tcdA, tcdB 0 1 0 0
MOH-Y 20.0% (1) III tcdA, tcdB, cdtA 0 0 1 0
OS-A 20.0% (1) Not tested None 0 0 1 0
n = number of samples.
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MRSA in infection or colonization of patients or healthcare
workers is not known. In the present study, MRSA was
identified in air samples from a nurses’ work station as well
as the area located outside the elevator doors. As hospital
personnel, patients, and visitors were present in these areas
during sampling, it is possible that dust or shed squames
containing MRSA from nearby surfaces, the ventilation
system, the disposal of linen, or an individual colonized
with MRSA may have introduced MRSA in these areas.
In the three participating hospitals, MRSA or C. diffi-
cile were recovered from unused (clean) linen and/or
isolation gowns. Possible reasons for these surfaces being
identified with HA pathogens may include contamination
from staff, patients, or visitors, cross-contamination from
a contaminated storage cart, or contamination during the
laundry process. Therefore, it may be necessary to clean
and disinfect storage carts to prevent cross-contamination
in addition to conducting an audit of the laundry process
Table 6 Univariable logistic regression analysis of variables associated with MRSA contamination
Variable Description OR 95% CI P-value
Hospital A Referent
B 1.23 0.66-2.30 0.503
C 1.54 0.83-2.85 0.169
Ward Medicine Referent
Surgery 1.21 0.74-1.98 0.443
Surface material Plastic Referent
Air 0.75 0.25-2.27 0.615
Fabric 2.41 1.31-4.43 0.005
Laminate 1.71 0.65-4.50 0.277
Metal 1.38 0.61-3.13 0.446
Othera 1.65 0.58-4.66 0.346
Surface location Public access Referent
Staff access 0.96 0.55-1.67 0.881
Type of surface Computer keyboard Referent
Blood pressure machine 0.88 0.15-5.06 0.885
Chair back 3.47 1.04-11.60 0.044
Counter top 2.32 0.54-10.02 0.260
Drug cart 2.32 0.54-10.02 0.260
Elevator areab 1.74 0.36-8.35 0.489
Elevator panel 0.97 0.17-5.58 0.970
Hand rail 3.50 0.95-12.93 0.060
Isolation cart 3.02 0.75-12.23 0.121
Isolation gown 1.53 0.26-9.00 0.640
Linen 1.12 0.24-5.26 0.890
Nursing stationb 0.60 0.06-5.69 0.660
Otherc 1.96 0.58-6.57 0.276
Patient chart 0.74 0.13-4.26 0.739
Sofa 8.16 2.22-29.97 0.002
Supply cart 2.07 0.34-12.47 0.426
Telephone 0.73 0.08-6.87 0.779
C. difficile Negative Referent
Positive 2.19 0.59-8.16 0.244
a Includes: leather (n=2), mixed (n=19), and wood (n=17).
b Air samples.
c Surfaces include: antibacterial wipes container (n=10), brochure holder (n=3), bulletin board (n=11), chart holder (n=9), clip board (n=8), door knob (n=9), glove
box holder (n=6), heating oven handle (n=7), lamp shade (n=3), lifter handle (n=3), sofa pillow (n=3), urine collection container (n=5), visiting room – air (n=3).
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to ensure that linen and isolation gowns are not contami-
nated prior to use.
Chair backs, hand rails, isolation carts, and sofas, had
an increased odds of being contaminated with MRSA
compared to computer keyboards. Model-based con-
trasts also demonstrated that these four surfaces had
increased odds of MRSA contamination compared to
other surfaces that were commonly found in the general
environment of hospital wards. In addition, Figure 1
illustrates that sofas are especially prone to MRSA con-
tamination. Many of the sampled surfaces were common
hand-touch sites not only by hospital personnel but also
patients and visitors, thereby increasing the rates of con-
tact along with the number of different people having
contact, and subsequently the potential for contamin-
ation and transmission. Furthermore, certain surfaces
may also be at increased odds for contamination due
to the inherent difficulty in cleaning them. Surface
material was statistically significant in the univariable
analysis, but not in the final model for MRSA contamin-
ation. While no significant association was identified,
fabric, laminate, and plastic surfaces were found to be
contaminated with MRSA and C. difficile on multiple
occasions and experiments conducted using swatches of
fabric and plastic have demonstrated that staphylococci
can survive days to months after drying on these types
of surfaces [41]. Furthermore, as these surfaces can differ
in their texture, they may be more difficult to adequately
clean and disinfect. Accordingly, further study of the in-
fluence of surface type on the prevalence and persistence
of contamination is indicated.
In Canada, epidemic MRSA clones have been desig-
nated using pulsed-field gel electrophoresis (PFGE)
[26,42]. While PFGE was not performed in this study, a
PFGE clone can be inferred from spa typing [26]. In
Hospital A, spa types consistent with CMRSA-2 predo-
minated in both the environment and patients, which is
unsurprising since CMRSA-2 is the leading cause of
HA-MRSA in Canada [43]. In Hospital B, CMRSA-2
predominated in the environment while both CMRSA-2
and CMRSA-5 were found in patients. CMRSA-5 is an
uncommon human epidemic clone typically associated
with HA-MRSA infection [43], but is common in people
that have contact with horses [44]. Interestingly, in
Table 7 Multivariable logistic regression model of variables associated with MRSA contamination
Variable Description OR 95% CI P-value
Hospital A Referent
B 1.36 0.69-2.65 0.373
C 1.19 0.61-2.35 0.606
Surface location Public access Referent
Staff access 1.99 0.82-4.78 0.126
Type of surface Computer keyboard Referent
Blood pressure machine 1.58 0.23-10.78 0.638
Chair back 3.94 1.12-13.86 0.032
Counter top 3.95 0.76-20.40 0.101
Drug cart 4.63 0.85-25.17 0.076
Elevator areaa 3.03 0.52-17.54 0.216
Elevator panel 1.72 0.25-11.74 0.580
Hand rail 6.35 1.38-29.15 0.017
Isolation cart 5.33 1.07-26.44 0.041
Isolation gown 2.60 0.37-18.19 0.336
Linen 2.02 0.35-11.56 0.430
Nursing stationa 0.52 0.05-4.92 0.567
Otherb 3.24 0.78-13.40 0.105
Patient chart 0.76 0.13-4.35 0.754
Sofa 12.92 2.97-56.25 0.001
Supply cart 2.73 0.42-17.83 0.295
Telephone 0.87 0.09-8.35 0.904
a Air samples.
b Surfaces include: antibacterial wipes container (n=10), brochure holder (n=3), bulletin board (n=11), chart holder (n=9), clip board (n=8), door knob (n=9), glove
box holder (n=6), heating oven handle (n=7), lamp shade (n=3), lifter handle (n=3), sofa pillow (n=3), urine collection container (n=5), visiting room – air (n=3).
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Hospital C, CMRSA-5 was most common in the
environment while CMRSA-2 and CMRSA-10 were pre-
dominant patient clones. CMRSA-5 was not identified
in any patient in Hospital C. The apparent disconnect
between patient and environmental MRSA clone dis-
tribution in Hospital C is interesting and may suggest
unidentified reservoirs or sources, such as hospital staff,
visitors, or unscreened patients.
To our knowledge, this is the first report of spa type
539/t034 contaminating the hospital environment in
Canada. This spa type is associated with the livestock-
associated (LA) sequence type (ST) 398, although recent
evidence indicates it is actually most likely a human
S. aureus clone that moved into livestock and subse-
quently acquired methicillin-resistance [45]. This spa
type is an important cause of community-associated
MRSA infection in some regions, particularly northern
Europe, most often in individuals with contact with pigs
[46–48]. Although this MRSA strain is endemic in the
swine population in Canada [49,50] and has also been
found in a horse [51] and dogs [52], its role in human
infections is unclear. A limited number of human infec-
tions have been reported [53], and it remains to be
determined whether this is a rare endemic infection, an
under diagnosed problem, or an emerging disease in
Canada. The relatively high prevalence of environmental
contamination with LA-MRSA was surprising given that
reports of human infection and colonization in Canada
are uncommon and the absence of this strain in patients
in this study. The three participating hospitals serve
rural communities where pig farming is present, which
may increase the likelihood of LA-MRSA exposure.
Despite environmental contamination, HA infection with
ST398 MRSA was not identified, which is perhaps
because this particular clone is known to be relatively
inefficiently transmitted in hospitals [54], and is probably
less infectious than typical human epidemic clones.
Therefore, it is not unreasonable to suspect that spa
type 539/t034 could be present in colonized patients,
Table 8 Based on the multivariable logistic regression
model, significant model-based contrasts between
surfaces contaminated with MRSA
Surfaces OR 95% CI P-value
Chair back versus Computer keyboard 3.94 1.12-13.86 0.032
Chair back versus Patient chart 5.22 1.06-25.63 0.042
Hand rail versus Computer keyboard 6.35 1.38-29.15 0.017
Hand rail versus Nursing station (air) 12.25 1.18-127.21 0.036
Hand rail versus Patient chart 8.40 1.39-50.97 0.021
Isolation cart versus Computer keyboard 5.33 1.07-26.44 0.041
Isolation cart versus Patient chart 7.05 1.09-45.62 0.040
Sofa versus Blood pressure machine 8.15 1.55-42.81 0.013
Sofa versus Chair back 3.28 1.05-10.24 0.041
Sofa versus Computer keyboard 12.92 2.97-56.25 0.001
Sofa versus Elevator panel 7.51 1.43-39.55 0.017
Sofa versus Linen 6.39 1.51-27.12 0.012
Sofa versus Nursing station (air) 24.91 2.51-247.15 0.006
Sofa versus Othera 3.99 1.38-11.52 0.011
Sofa versus Patient chart 17.09 2.95-99.12 0.002
Sofa versus Telephone 14.85 1.55-142.79 0.019
a Surfaces include: antibacterial wipes container (n=10), brochure holder (n=3),
bulletin board (n=11), chart holder (n=9), clip board (n=8), door knob (n=9),
glove box holder (n=6), heating oven handle (n=7), lamp shade (n=3),
lifter handle (n=3), sofa pillow (n=3), urine collection container (n=5), visiting
room – air (n=3).
Figure 1 Mean predicted probability for MRSA to be cultured from surfaces in the general environment. * Surfaces include: antibacterial
wipes container, brochure holder, bulletin board, chart holder, clip board, door knob, glove box holder, heating oven handle, lamp shade, lifter
handle, sofa pillow, urine collection container, visiting room – air.
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healthcare workers, or visitors in the absence of recog-
nized disease in a facility.
In the present study, eight different C. difficile ribo-
types were identified in the general environment, with
six being toxigenic and therefore clinically relevant.
However, care must be taken when interpreting the
C. difficile typing data due to the small number of iso-
lates. Overall, toxinotype 0 (MOH-T and MOH-0) was
the most prevalent, but was identified in Hospital C
only. The hypervirulent ribotypes 027 and 078 were also
identified in the environment of Hospital A and/or B,
along with ribotypes MOH-AD and MOH-C. The pre-
dominance of toxinotypes 0 and III (ribotype 027) in the
environment is not surprising since these were the most
common toxinotypes in an earlier study of hospitalized
patients in Ontario [55]. However, in that particular
study, the highest prevalence of toxinotype 0 strains was
associated with ribotype 001, which was not identified in
the present investigation.
Currently, there is no universally accepted standard
for the surveillance of pathogens from surfaces in the
hospital environment [56–58]. A variety of sampling
techniques have been employed to recover MRSA and
C. difficile from the hospital environment including dry
or moistened swabs [12,56], sterile gauze pads [13], ster-
ile electrostatic cloths [57], and contact plates [17,56].
Experiments have demonstrated that contact plates had
a higher efficiency compared to culture swabs for the re-
covery of C. difficile [59]. However, for MRSA, reports
of contact plates [58] and specific types of culture swabs
[56] have been identified as efficient and sensitive
sampling techniques, respectively. Although contact
plates can be processed more quickly than culture swabs
[56], contact plates are typically limited to sampling flat
surfaces [56,58] whereas culture swabs can be used on
irregular surfaces [58]. Like culture swabs, electrostatic
cloths can be used to sample irregular surfaces and
are also inexpensive, simple to use, and easy to sterilize
[57]. In a recent study evaluating C. difficile contamin-
ation in households, Weese and colleagues [60] isolated
C. difficile from 5.3% (95% CI 3.8-7.0%) of surfaces
using similar sampling and culturing methods as the
present investigation.
The present study has several limitations. First, cau-
tion should be exercised when interpreting some of the
results. For example, although sofas were significantly
associated with MRSA contamination, they only consti-
tuted seven surfaces in the entire study. Second, not all
environmental surfaces were sampled each week. Rea-
sons for surfaces not being sampled four times included
equipment/surfaces that had been cleaned by house-
keeping the morning of sampling or equipment that was
being used by hospital personnel or patients at the time
of sampling. This lack of sampling follow-through may
bias the overall prevalence of MRSA and C. difficile con-
tamination in the hospital environment. Lastly, the dis-
cordance of MRSA strains and C. difficile ribotypes
between the general environment and patient specimens
may be attributed to isolates that were not collected
and/or patients with MRSA or C. difficile that were not
identified during the study period.
Conclusions
The present study demonstrated that MRSA and C. diffi-
cile were identified from a number of different surfaces
in the general ward environment. However, there was no
correlation between MRSA and C. difficile contamin-
ation on these surfaces. As isolation carts, hand rails,
chair backs, and sofas were at increased odds of being
contaminated with MRSA, protocols are required to
ensure that these surfaces are adequately cleaned and
disinfected regularly. The identification of LA-MRSA
strains in the environment but not patient population
in Hospitals A and B requires further surveillance for a
better understanding of the epidemiology and microbiol-
ogy of this emerging MRSA strain. Further studies
regarding contact rates among hospital surfaces, type
of surface material, and the populations using these sur-
faces are warranted.
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